Statins and the vasculopathy of systemic sclerosis: Potential therapeutic agents?

This publication has 34 references indexed in Scilit:

• A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism
  Annals of the Rheumatic Diseases, 2004
• Simvastatin modulates TNFα-induced adhesion molecules expression in human endothelial cells
  Life Sciences, 2004
• Differential effects of simvastatin on mesangial cells
  Kidney International, 2004
• Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
  JAMA, 2002
• The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
  Nature, 2002
• Atherosclerosis — An Inflammatory Disease
  New England Journal of Medicine, 1999
• SYSTEMIC SCLEROSIS
  Rheumatic Disease Clinics of North America, 1996
• Effect of Pravastatin on Outcomes after Cardiac Transplantation
  New England Journal of Medicine, 1995
• Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.
  Journal of Clinical Investigation, 1995
• Regulation of the mevalonate pathway
  Nature, 1990